Effects of ticagrelor on endothelial progenitor cell level compared to clopidogrel in patients acute coronary syndrome

Trial Profile

Effects of ticagrelor on endothelial progenitor cell level compared to clopidogrel in patients acute coronary syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top